Literature DB >> 11352717

Design in topographical space of peptide and peptidomimetic ligands that affect behavior. A chemist's glimpse at the mind--body problem.

V J Hruby1.   

Abstract

Efforts to determine the bioactive conformations of peptide ligands for membrane-bound proteins such as G-protein-coupled receptors (GPCRs) have been particularly challenging due to the flexibility of the ligands and the lack of 3D structural information (X-ray, NMR, etc.) for integral membrane proteins. An approach to determining these conformations by conformational constraint of the backbone template (phi and psi angles) and by topographical constraint (chi(1), chi(2), etc. constraint) is outlined. Special attention is given to peptide neurotransmitter ligands that affect critical behaviors (feeding, sexual, addiction, pain, etc.). It is demonstrated that small changes in structure or a single torsional angle are sufficient to dramatically modify complex behaviors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11352717     DOI: 10.1021/ar990063q

Source DB:  PubMed          Journal:  Acc Chem Res        ISSN: 0001-4842            Impact factor:   22.384


  10 in total

1.  Utilize conjugated melanotropins for the earlier diagnosis and treatment of melanoma.

Authors:  Minying Cai; Zhonglin Liu; Hongchang Qu; Helen Fan; Zhiping Zheng; Victor J Hruby
Journal:  Eur J Pharmacol       Date:  2011-02-16       Impact factor: 4.432

2.  Engineering strategy to improve peptide analogs: from structure-based computational design to tumor homing.

Authors:  David Zanuy; Francisco J Sayago; Guillem Revilla-López; Gema Ballano; Lilach Agemy; Venkata Ramana Kotamraju; Ana I Jiménez; Carlos Cativiela; Ruth Nussinov; April M Sawvel; Galen Stucky; Erkki Ruoslahti; Carlos Alemán
Journal:  J Comput Aided Mol Des       Date:  2012-12-14       Impact factor: 3.686

Review 3.  Design of peptide and peptidomimetic ligands with novel pharmacological activity profiles.

Authors:  Victor J Hruby; Minying Cai
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013       Impact factor: 13.820

4.  Lipophilic Isosteres of a π-π Stacking Interaction: New Inhibitors of the Bcl-2-Bak Protein-Protein Interaction.

Authors:  Naeem Yusuff; Michaël Doré; Carol Joud; Michael Visser; Clayton Springer; Xiaoling Xie; Kara Herlihy; Dale Porter; B Barry Touré
Journal:  ACS Med Chem Lett       Date:  2012-05-27       Impact factor: 4.345

Review 5.  Design of novel melanocortin receptor ligands: multiple receptors, complex pharmacology, the challenge.

Authors:  Victor J Hruby; Minying Cai; James Cain; Joel Nyberg; Dev Trivedi
Journal:  Eur J Pharmacol       Date:  2011-01-03       Impact factor: 4.432

Review 6.  Organic chemistry and biology: chemical biology through the eyes of collaboration.

Authors:  Victor J Hruby
Journal:  J Org Chem       Date:  2009-12-18       Impact factor: 4.354

7.  Design, synthesis, and pharmacological activities of dynorphin A analogues cyclized by ring-closing metathesis.

Authors:  Wei-Jie Fang; Yanjun Cui; Thomas F Murray; Jane V Aldrich
Journal:  J Med Chem       Date:  2009-09-24       Impact factor: 7.446

8.  Synthesis of Boc-protected bicycloproline.

Authors:  Sujeewa Ranatunga; Juan R Del Valle
Journal:  Tetrahedron Lett       Date:  2009-05-27       Impact factor: 2.415

9.  Proline editing: a general and practical approach to the synthesis of functionally and structurally diverse peptides. Analysis of steric versus stereoelectronic effects of 4-substituted prolines on conformation within peptides.

Authors:  Anil K Pandey; Devan Naduthambi; Krista M Thomas; Neal J Zondlo
Journal:  J Am Chem Soc       Date:  2013-03-11       Impact factor: 15.419

10.  (2R,1'S,2'R)- and (2S,1'S,2'R)-3-[2-Mono(di,tri)fluoromethylcyclopropyl]alanines and their incorporation into hormaomycin analogues.

Authors:  Armin de Meijere; Sergei I Kozhushkov; Dmitrii S Yufit; Christian Grosse; Marcel Kaiser; Vitaly A Raev
Journal:  Beilstein J Org Chem       Date:  2014-12-03       Impact factor: 2.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.